Associations of Mammalian Target of Rapamycin Inhibitors with Post-Transplant Malignancies and All-Cause Mortality: Cause-Specific Competing Risks and Composite Outcomes Analyses
Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis
Pd-1 Inhibitor Treatment in Solid Organ Transplant Patients with Metastatic Cancer
Review of Outcomes After Diagnosis of Malignancy in Kidney Transplant Patients: Unos Database
Use of Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients: A Scoping Review
American Transplant Congress abstracts